MenACWY-TT (Nimenrix)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MenACWY-TT (Nimenrix), covering 2020-10-12 to 2020-10-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered). [Phase 3]